✦ LIBER ✦

A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease

✍ Scribed by R. E. Mansel; P. E. Preece; L. E. Hughes

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 409 KB
Volume: 65
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800651015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of vascular damage in sclerod

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril

✍ A. E. Gliddon; C. J. Doré; C. M. Black; N. McHugh; R. Moots; C. P. Denton; A. He 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract ## Objective To evaluate the efficacy and tolerability of prolonged administration of quinapril, a long‐acting angiotensin‐converting enzyme inhibitor, in the management of the peripheral vascular manifestations of limited cutaneous systemic sclerosis (lcSSc) and in the prevention of t

The safety and efficacy of a JAK inhibit

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

✍ Joel M. Kremer; Bradley J. Bloom; Ferdinand C. Breedveld; John H. Coombs; Mark P 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

A prospective, double-blind, randomized,

A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

✍ Bin Nie; Wan-Jun Cheng; Yan-Fang Li; Zheng Cao; Qing Yang; Ying-Xin Zhao; Yong-H 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Rapid and sustained improvement in bone

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

✍ Patrick Garnero; Elizabeth Thompson; Thasia Woodworth; Josef S. Smolen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 2 views

## Abstract ## Objective To investigate the effects of tocilizumab (TCZ) added to a stable dosage of methotrexate (MTX) on biochemical markers of bone and cartilage metabolism in patients in the multicenter double‐blind, placebo‐controlled OPTION (Tocilizumab Pivotal Trial in Methotrexate Inadequa